IssuerAnnouncementDetailsV2Portlet
Actions
Mouwasat Medical Services Co. announces its Annual Financial Results for the Period Ending on 2022-12-31
| Element List | Current Year | Previous Year | %Change | ||
|---|---|---|---|---|---|
| Sales/Revenue | 2,334 | 2,144 | 8.86 | ||
| Gross Profit (Loss) | 1,099 | 996 | 10.34 | ||
| Operational Profit (Loss) | 663 | 622 | 6.59 | ||
| Net Profit (Loss) after Zakat and Tax | 599 | 578 | 3.63 | ||
| Total Comprehensive Income | 594 | 575 | 3.3 | ||
| Total Share Holders Equity (after Deducting Minority Equity) | 2,923 | 2,604 | 12.25 | ||
| Profit (Loss) per Share | 5.99 | 5.78 | |||
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the net profit during the current year compared to the last year is | The reason for increase in net profit during the current year compared with the previous year is due to: 1- Increase in generated operating income as a result of: - A. The increase in the number of visits in the outpatient sector and the increase in occupancy rates in the internal departments B. Continued performance improvement of newly specialized resources. C. Continuous enhancement of operating efficiency of the available resources. 2- Increase in other revenues. It is worth mentioning that the decrease in profit margins during the current year compared with the previous year is due to the increase in operating and non-operating expenses related to the operation of the Dammam Hospital Expansion Project and the new Mouwasat Hospital in Madinah. |
| Statement of the type of external auditor's report | Unmodified opinion |
| Reclassification of Comparison Items | No reclassification. |
| Additional Information | The company would like to indicate the possibility of sending investors and financial analysts’ inquiries via email (Shares@mouwasat.com) within 6 working days from the date of publishing the financial statements |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 136.0
Net Change 1.4 (+1.04%)
Value Traded (Sar) 40,766,769.8
Volume Traded 299,259
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions